StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sangamo Therapeutics (SGMO) Hits Pre-Market High, Up 26%
April 2, 2019 8:09 AM
Sangamo Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Sangamo Therapeutics (SGMO) Prices 11M Share Common Offering at $11.50/Sh
April 4, 2019 8:03 AM
Sangamo Therapeutics (SGMO) Continues to Gain, Now Up 50%
April 2, 2019 8:39 AM
Sangamo Therapeutics (SGMO) Reports Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data
April 2, 2019 7:06 AM
Sangamo Therapeutics (SGMO), Pfizer (PFE) Report Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy
April 2, 2019 7:01 AM
Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data
April 2, 2019 7:00 AM
Sangamo Announces Agreement Securing Access To Large-Scale, Commercial-Grade Manufacturing Capacity At Brammer Bio
April 2, 2019 7:00 AM
Sangamo and Pfizer Announce Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy
April 2, 2019 7:00 AM
Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy
April 2, 2019 7:00 AM
